| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Drug Development | Executive VP, Drug Development
2 companies
Manhard Kimberly is an EVP, Drug Development at HERON THERAPEUTICS, INC. /DE/ with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sale+OE | 18,000 | $30.00 | $540,000.00 | -100% | |
| Jan 10, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sale+OE | 7,584 | $20.00 | $151,680.00 | -100% | |
| Apr 24, 2017 | HRTX Heron Therapeutics, Inc. /de/ | Executive VP, Drug Development | Sale+OE | 21,542 | $15.33 | $330,262.56 | -100% | |
| Jun 2, 2015 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sale+OE | 13,208 | $23.09 | $304,918.36 | -100% |